FDA NDC Directory · JSON-LD · Markdown

Duloxetine

NDC 70954-861 · HUMAN PRESCRIPTION DRUG · CAPSULE, DELAYED RELEASE

Labeler / ManufacturerANI Pharmaceuticals, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA202336
Dosage form / routeCAPSULE, DELAYED RELEASE · ORAL
Active ingredientsDULOXETINE HYDROCHLORIDE (30 mg/1)
Marketing started20260713
Package count1

External sources

Source: openFDA. Public-domain (CC0).